This study first validated the oncogenic roles of IQGAP1 in glioma using Immunohistochemistry analysis, which showed that the protein expression level of IQGAP1 in GBMLGG were higher than those in the normal adjacent tissues. This evidence concerns the gene IQGAP1 and central nervous system cancer.